Martin H. Huber Jr. Mersana Therapeutics, Inc. (MRSN) insider trading activity

MRSN Quotes by TradingView

Martin H. Huber Jr. is President, CEO of Mersana Therapeutics, Inc.. Currently has a direct ownership of 116,327 shares of MRSN, which is worth approximately $230,327. The most recent transaction as insider was on Sep 12, 2024, when has been sold 50,423 shares (Common Stock) at a price of $1.76 per share, resulting in proceeds of $88,744. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K
704.09% 3M change
704.09% 12M change
Total Value Held $230,327

Martin H. Huber Jr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 12 2024
SELL
Open market or private sale
$88,744 $1.76 p/Share
50,423 Reduced 30.24%
116,327 Common Stock
Sep 11 2024
BUY
Exercise of conversion of derivative security
-
166,750 Added 50.0%
166,750 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
14,467 Added 50.0%
14,467 Common Stock

Also insider at

SNDX
Syndax Pharmaceuticals Inc Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
PRESIDENT AND HEAD OF R&D
MHH

Martin H. Huber Jr.

President, CEO
Waltham, MA

Track Institutional and Insider Activities on MRSN

Follow Mersana Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRSN shares.

Notify only if

Insider Trading

Get notified when an Mersana Therapeutics, Inc. insider buys or sells MRSN shares.

Notify only if

News

Receive news related to Mersana Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRSN